NCT01873989View on ClinicalTrials.gov

Testosterone Replacement for Male Opioid Agonist Maintained Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Chronic PainOpioid AddictionSymptomatic Hypogonadism
Interventions
DRUG

Testosterone replacement

OTHER

Waitlist control

Trial Locations (1)

06519

MRU, APT Foundation, Inc, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT01873989 - Testosterone Replacement for Male Opioid Agonist Maintained Patients | Biotech Hunter | Biotech Hunter